Sort
53,477 grants matching “addiction”
Dynorphin/kappa-opioid receptor regulation of nucleus accumbens synaptic transmission
$405,436Antonello Bonci · National Institute On Drug Abuse · ZIA · FY2015 · DA
Southern Consortium Node of the Clinical Trials Network
$405,432Kathleen Theresa Brady · Medical University Of South Carolina · UG1 · FY2022 · DA
Cost, Benefit & Regulation of Buprenorphine Treatment for Medicaid Beneficiaries
$405,376Robin E. Clark · Univ Of Massachusetts Med Sch Worcester · R01 · FY2011 · DA
Immunotherapeutic Targeting CD74 as a Treatment for Stimulant Use Disorder
$405,334Renee Lynn Shirley · Virogenomics Biodevelopment, Inc. · R41 · FY2024 · DA
Advancing Nr4a1 as a novel target in cocaine use disorder.
$405,230Elizabeth A Heller · Rafias Llc · R41 · FY2025 · DA
PHARMACOKINETICS OF PSYCHOSTIMULANTS AND REINFORCEMENT
$405,228Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2001 · DA
Synthesis of Incongruent Temporal Information
$405,214Matthew S Matell · Villanova University · R15 · FY2011 · DA
Psychology Training Alcohol Research
$405,197Mary E Larimer · University Of Washington · T32 · FY2009 · AA
Transgenerational Effects of Drug-exposure: Epigenetic and Behavioral Impact
$405,182Julie A Blendy · University Of Pennsylvania · R01 · FY2014 · DA
Tailored Self-Management of TMD Pain using Health Information Technology
$405,157James Ryan Fricton · Healthpartners Institute · U01 · FY2017 · DE
Brain Imaging and Pain: Analysis of Placebo Analgesia
$405,075Michael E Robinson · University Of Florida · R01 · FY2021 · AT
Genomic Resource Grant for PhenX Toolkit - expansion and sustainability: Resource Informatics
$405,064Carol M Hamilton · Research Triangle Institute · U41 · FY2017 · HG
Small Molecule Libraries Targeted to CBP and Attenuation AfosB Expression
$405,049Michael Ohlmeyer · Icahn School Of Medicine At Mount Sinai · R33 · FY2013 · DA
Rutgers Training in Addiction Research Program
$405,022Robert Christopher Pierce · Rutgers Biomedical And Health Sciences · T32 · FY2025 · DA
Medication development of agonist-type treatment agents for stimulant addiction
$405,008Amy Hauck Newman · National Institute On Drug Abuse · ZIA · FY2012 · DA
Region-Specific, Inducible Axonal Tract-Tracing in the Brain
$405,000David J Anderson · California Institute Of Technology · R01 · FY2010 · MH
The role of the nigrothalamic pathway in opioid-driven behaviors
$405,000Ewa Joanna Galaj · Colgate University · R15 · FY2023 · DA
REU Site: Human-Centered Computing for Social Good
$404,983Evan Rosenberg · University Of Minnesota-Twin Cities · · FY2021 · CSE
A novel inhaled dry powder psychoplastogenic formulation for treating persons with opioid use disorder
$404,917Bryce Beverlin II · Quench Medical, Inc. · R43 · FY2024 · DA
Development of Ligands for Nicotinic Receptors
$404,901Research Triangle Institute · R01 · FY2004 · DA
Drivers of histologic transformation in EGFR-mutant lung cancer
$404,888Helena Yu · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Drivers of histologic transformation in EGFR-mutant lung cancer
$404,888Helena Yu · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Basic Science Training Program in Drug Abuse
$404,885Amelia J Eisch · Ut Southwestern Medical Center · T32 · FY2010 · DA
Effects of voluntary exercise on reinstatement of cocaine seeking
$404,842David Weinshenker · Emory University · R01 · FY2012 · DA
Heal(th) From Within: A Research Collaborative to Share our Journeys to Wellness
$404,822Tara Ford · Alaska Native Tribal Health Consortium · OT2 · FY2025 · DA